1. Home
  2. MRK vs RILYP Comparison

MRK vs RILYP Comparison

Compare MRK & RILYP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRK
  • RILYP
  • Stock Information
  • Founded
  • MRK 2000
  • RILYP 1973
  • Country
  • MRK United States
  • RILYP United States
  • Employees
  • MRK N/A
  • RILYP N/A
  • Industry
  • MRK Biotechnology: Pharmaceutical Preparations
  • RILYP Investment Managers
  • Sector
  • MRK Health Care
  • RILYP Finance
  • Exchange
  • MRK Nasdaq
  • RILYP Nasdaq
  • Market Cap
  • MRK 198.5B
  • RILYP N/A
  • IPO Year
  • MRK N/A
  • RILYP N/A
  • Fundamental
  • Price
  • MRK $81.54
  • RILYP $4.91
  • Analyst Decision
  • MRK Buy
  • RILYP
  • Analyst Count
  • MRK 15
  • RILYP 0
  • Target Price
  • MRK $112.57
  • RILYP N/A
  • AVG Volume (30 Days)
  • MRK 17.6M
  • RILYP 31.7K
  • Earning Date
  • MRK 07-29-2025
  • RILYP 01-01-0001
  • Dividend Yield
  • MRK 3.97%
  • RILYP 17.50%
  • EPS Growth
  • MRK 667.14
  • RILYP N/A
  • EPS
  • MRK 6.88
  • RILYP N/A
  • Revenue
  • MRK $63,922,000,000.00
  • RILYP $854,383,000.00
  • Revenue This Year
  • MRK $2.26
  • RILYP N/A
  • Revenue Next Year
  • MRK $5.79
  • RILYP N/A
  • P/E Ratio
  • MRK $11.87
  • RILYP N/A
  • Revenue Growth
  • MRK 4.10
  • RILYP N/A
  • 52 Week Low
  • MRK $73.31
  • RILYP $1.73
  • 52 Week High
  • MRK $129.03
  • RILYP $20.00
  • Technical
  • Relative Strength Index (RSI)
  • MRK 52.24
  • RILYP 80.65
  • Support Level
  • MRK $82.26
  • RILYP $2.02
  • Resistance Level
  • MRK $85.00
  • RILYP $4.78
  • Average True Range (ATR)
  • MRK 1.89
  • RILYP 0.44
  • MACD
  • MRK 0.19
  • RILYP 0.33
  • Stochastic Oscillator
  • MRK 49.59
  • RILYP 99.38

About MRK Merck & Company Inc. (new)

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

About RILYP B. Riley Financial Inc.

B. Riley Financial Inc is a diversified financial services company. The company through its subsidiaries offers investment banking and financial services to corporate, institutional, and high-net-worth clients and also asset disposition, valuation and appraisal, and capital advisory services to retail, wholesale, institutional, lenders, capital providers, private equity investors, and professional services firms in United States, Canada, and Europe. It also provides internet access and subscription services. The reportable operating segments of the company include Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications segment, and Consumer products segment.

Share on Social Networks: